4Moving Biotech develops targeted pharmacological treatments for osteoarthritis through specialized drug formulation techniques that enhance therapeutic efficacy and patient adherence. The company focuses on alleviating pain and improving mobility for osteoarthritis patients, ultimately aiming to enhance their quality of life.
Funding
$16.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Osteoarthritis patients often experience pain and reduced mobility, which significantly impacts their quality of life. Current pharmacological treatments may have limited efficacy or require frequent administration, leading to poor patient adherence.
Solution
4Moving Biotech develops targeted therapies for osteoarthritis by employing specialized drug formulation techniques designed to enhance therapeutic efficacy and improve patient adherence. The company focuses on creating innovative treatments that alleviate pain, reduce inflammation, and restore joint function. By optimizing drug delivery and formulation, 4Moving Biotech aims to provide osteoarthritis patients with more effective and convenient treatment options, ultimately improving their mobility and overall well-being. The company's approach involves translating scientific advancements into practical medical solutions, addressing the unmet needs of individuals suffering from osteoarthritis.
Target Audience
The primary target audience includes osteoarthritis patients seeking more effective and convenient treatment options to alleviate pain and improve mobility.
Features
- Specialized drug formulation techniques for enhanced therapeutic efficacy
- Targeted therapies designed to alleviate pain and reduce inflammation in osteoarthritic joints
- Optimized drug delivery for improved patient adherence and convenience